ONPH (Oncology Pharma) Total Equity: $-0.45 Mil (As of Dec. 2004)


What is Oncology Pharma Total Equity?

Oncology Pharma ONPH +13.21% Total Equity is $-0.45 Mil as of Dec. 2004.

Oncology Pharma's total equity for the quarter that ended in Dec. 2004 was $-0.45 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Oncology Pharma Total Equity Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Total Equity Chart

Oncology Pharma Annual Data
Trend Jun96 Jun97 Jun98 Mar00 Mar01 Mar02 Mar03
Total Equity
Get a 7-Day Free Trial -0.06 5.03 3.69 2.37 0.87

Oncology Pharma Quarterly Data
Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.17 -0.35 -0.37 -0.45

Oncology Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Oncology Pharma's Total Equity for the fiscal year that ended in Mar. 2003 is calculated as

Total Equity=Total Assets(Q: Mar. 2003 )-Total Liabilities(Q: Mar. 2003 )
=1.751-0.879
=0.87

Oncology Pharma's Total Equity for the quarter that ended in Dec. 2004 is calculated as

Total Equity=Total Assets(Q: Dec. 2004 )-Total Liabilities(Q: Dec. 2004 )
=0.043-0.489
=-0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-0.45 Mil mean?
Oncology Pharma (ONPH) has a Total Equity of $-0.45 Mil as of Dec. 2004. The total amount of equity as record on a company's balance sheet. View historical data for Oncology Pharma and its competitors.
Is Oncology Pharma's Total Equity too high?
Oncology Pharma's current Total Equity is $-0.45 Mil.
How does Oncology Pharma's Total Equity compare to TAUG and IMUN?
Oncology Pharma's Total Equity of $-0.45 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Diversified Financial Services company?
A good Total Equity depends on the Diversified Financial Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Oncology Pharma and its competitors. Oncology Pharma's current Total Equity is $-0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Total Equity of $-0.45 Mil. The current Total Equity is $-0.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Total Equity is $-0.45 Mil as of Dec. 2004. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc is a shell company and currently has no operations.